DELIVERY ORDER

FY27 B1 MCKESSON MEDICATION NOV 26

Awarded to MCKESSON CORPORATION

PIID 15B10227F00000009US · USAspendingBiotechnology & Pharmaceuticals
$176.2K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$176,208sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateNov 1, 2026
Company legal name
MCKESSON CORPORATION
UEI / CAGE
S1RUKWWRYFL6 / Not reported
Parent award
Not reported
Awarding agency
Department of Justice
Subagency
Federal Prison System / Bureau of Prisons
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6505
Performance period
Not reported — Not reported
Recipient address
6555 STATE HIGHWAY 161, IRVING, DALLAS, TX, 75039
Place of performance
ASHLAND, BOYD, KY, 41102
Source last modified
Oct 28, 2026

Description

FY27 B1 MCKESSON MEDICATION NOV 26

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    FY27 B1 MCKESSON MEDICATION NOV 26

    US · usaspendingSource ↗
  2. Value increased

    FY27 B1 MCKESSON MEDICATION NOV 26

    US · usaspending$176.2KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Oct 19, 20260Not reported$176,207.97Not reportedNot reportedFY27 B1 MCKESSON MEDICATION NOV 26USAspending ↗